Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Expanding Opioid REMS To Immediate Release Formulations

Jul 11 2017

• By Brenda Sandburg

Opioid abuse epidemic concept

Related Content

REMS Assessment Challenges Shine Through In Opioids Review

May 16 2016

Restrictive REMS Is Least Favored Path For Opioid Prescriber Education

May 09 2016

Opioid Prescriber Training: US FDA Still Debating Mandate; CMS Policies Having Impact Now

May 25 2017

Opioid REMS: New CME 'Blueprint' To Include Immediate-Release Drugs

May 25 2017

Opioid Policy At US FDA To Become 'More Forceful,' Gottlieb Says

May 24 2017

Curtain Falls On Opana ER As Endo Agrees To US FDA Withdrawal Request

Jul 06 2017

Related Companies

Endo, Inc.

Additional Topics

United States Drug Safety FDA Regulation Risk Management Neurology BioPharmaceutical

More from Drug Safety

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window